Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI040645-03
Application #
6149825
Study Section
Genome Study Section (GNM)
Program Officer
Klein, David L
Project Start
1998-02-01
Project End
2001-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
3
Fiscal Year
2000
Total Cost
$292,668
Indirect Cost
Name
University of Alabama Birmingham
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Johnston, Jason W; Myers, Lisa E; Ochs, Martina M et al. (2004) Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide. Infect Immun 72:5858-67
Robinson, D Ashley; Briles, David E; Crain, Marilyn J et al. (2002) Evolution and virulence of serogroup 6 pneumococci on a global scale. J Bacteriol 184:6367-75
Hollingshead, S K; Briles, D E (2001) Streptococcus pneumoniae: new tools for an old pathogen. Curr Opin Microbiol 4:71-7
Robinson, D A; Edwards, K M; Waites, K B et al. (2001) Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central Tennessee. J Infect Dis 183:1501-7
Briles, D E; Ades, E; Paton, J C et al. (2000) Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 68:796-800
Hollingshead, S K; Becker, R; Briles, D E (2000) Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 68:5889-900
Nabors, G S; Braun, P A; Herrmann, D J et al. (2000) Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 18:1743-54
Briles, D E; Hollingshead, S K; King, J et al. (2000) Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis 182:1694-701
Yung, D L; McIver, K S; Scott, J R et al. (1999) Attenuated expression of the mga virulence regulon in an M serotype 50 mouse-virulent group A streptococcal strain. Infect Immun 67:6691-4